In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant Agliadin T-cell epitope In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant Agliadin T-cell epitope2018-01-17T17:05:11-05:00
